
  
    
      
        Introduction_NNP
        BALB_NNP /_NN c_SYM mice_NNS immunized_JJ with_IN human_JJ cartilage_NN proteoglycan_NN
        (_( PG_NNP )_) (_( aggrecan_NN )_) develop_VB arthritis_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ]_NN ._.
        Autoantibody_NNP production_NN precedes_VBZ the_DT first_JJ clinical_JJ
        symptoms_NNS of_IN arthritis_NN [_NN 5_CD ]_NN ._. While_IN these_DT anti-_NN PG_NNP
        autoantibodies_NNS alone_RB do_VBP not_RB transfer_VB arthritis_NN ,_,
        autoantibodies_NNS significantly_RB hasten_VB the_DT onset_NN of_IN disease_NN
        and_CC cause_VB PG_NNP to_TO be_VB released_VBN from_IN the_DT cartilage_NN [_NN 6_CD ,_, 7_CD ]_NN ._.
        B_NN cells_NNS proliferate_VBP and_CC differentiate_VB into_IN
        immunoglobulin-secreting_JJ plasma_NN cells_NNS under_IN the_DT influence_NN
        of_IN a_DT combination_NN of_IN cytokines_NNS derived_VBN from_IN T_NN cells_NNS [_NN 8_CD ]_NN ._.
        IL-_NNP 4_CD ,_, a_DT T_NN helper_NN (_( Th_NNP )_) 2_CD cytokine_NN ,_, regulates_VBZ the_DT switch_NN from_IN
        IgM_NNP /_NN D_NNP to_TO IgG_NNP 1_CD and_CC IgE_NNP in_IN activated_VBN B_NNP cells_NNS [_NN 9_CD ,_, 10_CD ]_NN ._.
        However_RB ,_, the_DT 
        in_IN vivo_NN dependency_NN on_IN IL-_NNP 4_CD for_IN the_DT
        IgG_NNP 1_CD response_NN is_VBZ controversial_JJ [_NN 11_CD ,_, 12_CD ,_, 13_CD ]_NN ._. The_DT Th_NNP 1_CD
        cytokine_NN IFN-γ_NNP is_VBZ important_JJ 
        in_IN vitro_NN and_CC 
        in_IN vivo_NN for_IN enhancement_NN of_IN IgG_NNP 2_CD a_DT
        secretion_NN [_NN 14_CD ,_, 15_CD ]_NN ._. Th_NNP 1_CD and_CC Th_NNP 2_CD cytokines_NNS also_RB function_VBP to_TO
        cross-regulate_JJ Ig_NNP isotypes_NNS ._. For_IN example_NN ,_, IFN-γ_NNP antagonizes_NNS
        IL-_NNP 4_CD -_: induced_VBN IgG_NNP 1_CD responses_NNS at_IN the_DT level_NN of_IN IgG_NNP 1_CD
        transcription_NN [_NN 16_CD ,_, 17_CD ]_NN ,_, whereas_IN IL-_NNP 4_CD has_VBZ the_DT ability_NN to_TO
        suppress_VB IFN-γ-driven_NNP IgG_NNP 2_CD a_DT responses_NNS [_NN 16_CD ]_NN ._.
        We_PRP have_VBP previously_RB shown_VBN that_IN PG-specific_NNP antibodies_NNS
        increase_VBP the_DT severity_NN of_IN arthritis_NN and_CC that_IN PG-induced_NNP
        arthritis_NN is_VBZ a_DT Th_NNP 1_CD -_: type_NN disease_NN dominated_VBN by_IN IFN-γ_NNP [_NN 4_CD ]_NN ._. We_PRP
        therefore_RB were_VBD interested_JJ in_IN finding_VBG out_IN how_WRB IFN-γ_NNP and_CC IL-_NNP 4_CD
        regulate_VB isotype_NN expression_NN of_IN the_DT PG-specific_NNP antibodies_NNS
        and_CC if_IN an_DT autoantibody_NN isotype_NN contributes_VBZ to_TO the_DT severity_NN
        of_IN disease_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Animals_NNS
          BALB_NNP /_NN c_SYM and_CC IFN-γ-deficient_NNP mice_NNS were_VBD purchased_VBN from_IN
          the_DT Jackson_NNP Laboratory_NNP (_( Bar_NNP Harbor_NNP ,_, ME_NNP ,_, USA_NNP )_) ._. BALB_NNP /_NN c_SYM
          heterozygous_JJ and_CC homozygous_JJ nude_JJ mice_NNS were_VBD obtained_VBN from_IN
          the_DT National_NNP Cancer_NNP Institute_NNP (_( Frederick_NNP ,_, MD_NNP ,_, USA_NNP )_) ._.
          Breeding_NNP pairs_NNS of_IN BALB_NNP /_NN c_SYM IL-_NNP 4_CD -_: deficient_NN mice_NNS were_VBD
          obtained_VBN from_IN Klinische_NNP Forschergruppe_NNP für_NN Rheumatologie_NNP
          (_( Freiburg_NNP ,_, Germany_NNP )_) ._. CD_NNP 40_CD -_: deficient_NN BALB_NNP /_NN c_SYM mice_NNS were_VBD
          purchased_VBN from_IN Taconic_NNP (_( Germantown_NNP ,_, NY_NNP ,_, USA_NNP )_) ._.
        
        
          Preparation_NNP of_IN cartilage_NN PG_NNP monomer_NN (_( aggrecan_NN )_) and_CC
          immunization_NN
          Human_JJ cartilage_NN was_VBD obtained_VBN during_IN joint-replacement_JJ
          surgery_NN and_CC high-density_JJ PG_NNP was_VBD prepared_VBN as_IN described_VBN
          elsewhere_RB [_NN 1_CD ,_, 5_CD ]_NN ._. Female_NNP BALB_NNP /_NN c_SYM mice_NNS (_( wild-type_JJ or_CC gene_NN
          deficient_NN )_) were_VBD injected_VBN intraperitoneally_RB on_IN days_NNS 0_CD ,_, 21_CD ,_,
          and_CC 42_CD with_IN 100_CD μg_NN of_IN human_JJ cartilage_NN PG_NNP measured_VBD as_IN
          protein_NN ,_, in_IN adjuvant_NN ,_, as_IN described_VBN elsewhere_RB [_NN 1_CD ,_, 2_CD ,_,
          5_CD ]_NN ._.
        
        
          Measurement_NNP of_IN immunoglobulin_NN isotypes_NNS
          Enzyme-linked_NNP immunosorbent_NN assay_NN (_( ELISA_NNP )_) was_VBD used_VBN to_TO
          measure_VB isotype-specific_JJ antibodies_NNS in_IN serial_NN dilutions_NNS
          (_( 1_CD :_: 1000_CD to_TO 1_CD :_: 62_CD ,_, 500_CD )_) of_IN sera_NN ._. ELISA_NNP plates_NNS were_VBD coated_VBN
          with_IN either_DT 0_CD ._. 5_CD μg_NN human_JJ PG_NNP or_CC 1_CD μg_NN mouse_NN PG_NNP ,_, as_IN
          described_VBN elsewhere_RB [_NN 5_CD ,_, 18_CD ]_NN ._. PG-specific_NNP IgG_NNP isotypes_NNS
          were_VBD detected_VBN with_IN peroxidase-labeled_JJ rabbit_NN anti-mouse_JJ
          IgG_NNP 1_CD or_CC IgG_NNP 2_CD a_DT (_( Zymed_NNP Laboratories_NNPS ,_, San_NNP Francisco_NNP ,_, CA_NNP ,_,
          USA_NNP )_) ._. IgG_NNP 1_CD and_CC IgG_NNP 2_CD a_DT myeloma_NN proteins_NNS were_VBD used_VBN for_IN a_DT
          standard_JJ curve_NN ._.
        
        
          Assessment_NNP of_IN cytokine_NN production_NN by_IN spleen_NN cells_NNS
          in_IN vitro_NN
          Spleens_NNP were_VBD obtained_VBN 1_CD week_NN after_IN the_DT third_JJ injection_NN
          with_IN PG_NNP ,_, as_IN described_VBN elsewhere_RB [_NN 4_CD ]_NN ._. Cells_NNP were_VBD
          stimulated_VBN in_IN the_DT presence_NN or_CC absence_NN of_IN PG_NNP (_( 20_CD μg_NN /_NN ml_NN )_)
          and_CC a_DT capture_NN ELISA_NNP was_VBD used_VBN to_TO measure_VB the_DT released_VBN
          cytokines_NNS IFN-γ_NNP ,_, IL-_NNP 4_CD ,_, and_CC IL-_NNP 10_CD [_NN 4_CD ]_NN ._.
        
        
          Assessment_NNP of_IN arthritis_NN
          The_DT severity_NN of_IN arthritis_NN in_IN each_DT paw_NN was_VBD graded_JJ
          according_VBG to_TO an_DT established_VBN scoring_VBG system_NN [_NN 3_CD ,_, 5_CD ]_NN as_IN
          follows_VBZ :_: 0_CD ,_, normal_JJ ;_: 1_CD ,_, mild_JJ erythema_NN and_CC /_NN or_CC swelling_VBG ,_,
          usually_RB in_IN one_CD or_CC two_CD toes_NNS ;_: 2_CD ,_, moderate_JJ erythema_NN and_CC /_NN or_CC
          swelling_VBG of_IN the_DT paw_NN ;_: 3_CD ,_, more_JJR diffuse_NN erythema_NN ;_: 4_CD ,_, severe_JJ
          erythema_NN and_CC swelling_VBG affecting_VBG the_DT entire_JJ paw_NN (_( maximum_NN
          score_NN for_IN the_DT four_CD paws_NNS =_SYM 16_CD )_) ._. Inflammation_NNP and_CC joint_NN
          swelling_VBG were_VBD recorded_VBN twice_RB a_DT week_NN by_IN the_DT same_JJ
          individual_NN in_IN a_DT blinded_JJ manner_NN ._.
        
        
          Statistical_NNP analysis_NN
          The_DT Mann-_NNP Whitney_NNP 
          U_NNP test_NN was_VBD used_VBN to_TO compare_VB
          nonparametric_JJ data_NNS for_IN statistical_JJ significance_NN ._. 
          P_NN values_NNS less_JJR than_IN 0_CD ._. 05_CD were_VBD
          considered_VBN significant_JJ ._.
        
      
      
        Results_NNS
        
          PG-specific_NNP IgG_NNP 1_CD isotype_NN dominates_VBZ despite_IN a_DT higher_JJR
          ratio_NN of_IN IFN-γ_NNP to_TO IL-_NNP 4_CD
          BALB_NNP /_NN c_SYM mice_NNS immunized_JJ with_IN human_JJ PG_NNP generated_VBD a_DT
          PG-specific_NNP IgG_NNP 1_CD isotype_NN response_NN which_WDT was_VBD significantly_RB
          higher_JJR than_IN the_DT PG-specific_NNP IgG_NNP 2_CD a_DT isotype_NN (_( Fig_NNP ._. 1_LS a_DT )_) ._.
          However_RB ,_, when_WRB the_DT production_NN of_IN Th_NNP 1_CD and_CC Th_NNP 2_CD cytokines_NNS was_VBD
          measured_VBN from_IN splenocytes_NNS of_IN animals_NNS immunized_JJ with_IN PG_NNP ,_,
          IFN-γ_NNP was_VBD produced_VBN at_IN a_DT significantly_RB higher_JJR
          concentration_NN than_IN either_DT IL-_NNP 4_CD or_CC IL-_NNP 10_CD (_( Fig_NNP ._. 1_LS a_DT )_) ._. These_DT
          results_NNS reveal_VBP a_DT dichotomy_NN between_IN the_DT isotype_NN of_IN the_DT
          PG-specific_NNP antibody_NN response_NN (_( IgG_NNP 1_LS )_) and_CC the_DT secretion_NN of_IN
          IFN-γ_NNP ._. The_DT discrepancy_NN could_MD be_VB reconciled_JJ if_IN the_DT
          PG-specific_NNP IgG_NNP 1_CD response_NN is_VBZ independent_JJ of_IN T_NN cells_NNS ._.
          We_PRP therefore_RB assessed_VBD the_DT PG-specific_NNP response_NN in_IN
          heterozygous_JJ and_CC homozygous_JJ nude_JJ mice_NNS and_CC in_IN
          CD_NNP 40_CD -_: deficient_NN mice_NNS ._. Whereas_IN heterozygous_JJ nude_JJ mice_NNS
          generated_VBN essentially_RB the_DT same_JJ antibody_NN response_NN to_TO PG_NNP as_IN
          wild-type_JJ mice_NNS (_( Fig_NNP ._. 1_LS b_SYM )_) ,_, no_DT or_CC very_RB little_JJ anti-_NN PG_NNP
          antibody_NN was_VBD detected_VBN in_IN homozygous_JJ nude_JJ or_CC
          CD_NNP 40_CD -_: deficient_NN mice_NNS (_( Fig_NNP ._. 1_LS b_SYM )_) ._. These_DT results_NNS show_VBP that_IN
          the_DT human_NN and_CC murine_NN PG-specific_NNP antibody_NN responses_NNS are_VBP
          dependent_JJ on_IN the_DT interaction_NN between_IN T_NN cells_NNS and_CC B_NNP
          cells_NNS ._.
        
        
          IL-_NNP 4_CD and_CC IFN-γ_NNP regulation_NN of_IN the_DT PG-specific_NNP
          IgG_NNP 1_CD /_NN IgG_NNP 2_CD a_DT isotype_NN response_NN
          To_TO find_VB out_IN if_IN the_DT PG-specific_NNP IgG_NNP 1_CD response_NN is_VBZ
          dependent_JJ on_IN IL-_NNP 4_CD ,_, we_PRP immunized_JJ IL-_NNP 4_CD -_: deficient_NN mice_NNS with_IN
          PG_NNP and_CC measured_VBD the_DT PG-specific_NNP IgG_NNP 1_CD and_CC IgG_NNP 2_CD a_DT isotypes_NNS ._.
          Whereas_IN the_DT IgG_NNP 1_CD response_NN to_TO human_JJ PG_NNP was_VBD unaffected_JJ
          (_( Fig_NNP ._. 2_LS a_DT )_) ,_, the_DT loss_NN of_IN IL-_NNP 4_CD significantly_RB reduced_VBD the_DT
          IgG_NNP 1_CD response_NN to_TO mouse_NN PG_NNP in_IN IL-_NNP 4_CD -_: deficient_NN mice_NNS (_( Fig_NNP ._.
          2_LS b_SYM )_) ._. The_DT most_RBS striking_JJ observation_NN ,_, however_RB ,_, was_VBD the_DT
          dramatic_JJ increase_NN in_IN PG-specific_NNP IgG_NNP 2_CD a_DT response_NN in_IN IL-_NNP 4_CD
          deficient_NN mice_NNS ._. There_EX was_VBD a_DT sixfold_JJ increase_NN in_IN the_DT IgG_NNP 2_CD a_DT
          response_NN in_IN the_DT absence_NN of_IN IL-_NNP 4_CD (_( Fig_NNP ._. 2_LS a_DT ,_, b_SYM )_) ._. These_DT
          results_NNS show_VBP that_IN the_DT PG-specific_NNP IgG_NNP 1_CD response_NN was_VBD
          marginally_RB dependent_JJ on_IN IL-_NNP 4_CD ,_, whereas_IN endogenous_JJ IL-_NNP 4_CD
          dramatically_RB suppressed_VBD the_DT PG-specific_NNP IgG_NNP 2_CD a_DT
          response_NN ._.
          To_TO find_VB out_IN if_IN IFN-γ_NNP induced_VBD a_DT PG-specific_NNP IgG_NNP 2_CD a_DT
          response_NN 
          in_IN vivo_NN ,_, the_DT PG-specific_NNP IgG_NNP 2_CD a_DT
          response_NN was_VBD examined_VBN in_IN IFN-γ-deficient_NNP mice_NNS ._. The_DT IgG_NNP 2_CD a_DT
          antibody_NN responses_NNS to_TO both_DT human_NN and_CC mouse_NN PGs_NNP were_VBD lower_JJR
          in_IN these_DT mice_NNS than_IN in_IN wild-type_JJ mice_NNS (_( Fig_NNP ._. 2_LS a_DT ,_, b_SYM )_) ._. These_DT
          results_NNS show_VBP that_IN the_DT PG-specific_NNP IgG_NNP 2_CD a_DT response_NN was_VBD
          dependent_JJ on_IN IFN-γ_NNP ._. If_IN IFN-γ_NNP concentrations_NNS regulated_VBN
          IgG_NNP 1_CD ,_, reduction_NN in_IN IFN-γ_NNP should_MD be_VB permissive_JJ for_IN IgG_NNP 1_CD ;_:
          in_IN IFN-γ-deficient_NNP mice_NNS ,_, however_RB ,_, there_EX was_VBD no_DT increase_NN
          in_IN IgG_NNP 1_CD response_NN to_TO either_CC human_NN or_CC mouse_NN PG_NNP (_( Fig_NNP ._.
          2_LS a_DT ,_, b_SYM )_) ._.
        
        
          Arthritis_NNP is_VBZ associated_VBN with_IN an_DT increase_NN in_IN
          IgG_NNP 2_CD a_DT
          We_PRP studied_VBD the_DT induction_NN of_IN arthritis_NN in_IN mice_NNS
          deficient_NN in_IN IL-_NNP 4_CD and_CC IFN-γ_NNP to_TO find_VB out_IN if_IN there_EX is_VBZ a_DT
          correlation_NN between_IN the_DT isotype_NN of_IN the_DT antibody_NN and_CC
          disease_NN ._. In_IN wild-type_JJ and_CC IL-_NNP 4_CD deficient_NN mice_NNS ,_, paw_NN
          swelling_VBG began_VBD 11_CD ._. 6_CD ±_NN 6_CD ._. 6_CD days_NNS after_IN the_DT last_JJ injection_NN
          with_IN PG_NNP ,_, whereas_IN in_IN the_DT IFN-γ-deficient_NNP mice_NNS ,_, swelling_VBG
          began_VBD much_JJ later_RB at_IN 36_CD ._. 8_CD ±_NN 6_CD ._. 2_CD days_NNS (_( Table_NNP 1_LS )_) ._. The_DT
          incidences_NNS of_IN arthritis_NN in_IN wild-type_JJ and_CC IL-_NNP 4_CD -_: deficient_NN
          mice_NNS were_VBD much_RB higher_JJR than_IN in_IN the_DT PG-immunized_NNP
          IFN-γ-deficient_NNP mice_NNS ,_, and_CC the_DT arthritis_NN score_NN was_VBD
          significantly_RB higher_JJR in_IN the_DT IL-_NNP 4_CD -_: deficient_NN than_IN in_IN the_DT
          wild-type_JJ animals_NNS (_( Table_NNP 1_LS )_) ._. In_IN IFN-γ-deficient_NNP mice_NNS ,_, not_RB
          only_RB was_VBD the_DT proportion_NN of_IN animals_NNS with_IN arthritis_NN lower_JJR
          than_IN in_IN the_DT other_JJ groups_NNS ,_, but_CC also_RB their_PRP$ reduced_VBN
          susceptibility_NN was_VBD further_RBR mirrored_VBD in_IN the_DT significantly_RB
          less_RBR severe_JJ paw_NN swelling_VBG (_( Table_NNP 1_LS )_) ._. These_DT data_NNS show_VBP that_IN
          endogenous_JJ cytokine_NN concentrations_NNS dramatically_RB affect_VBP
          both_DT the_DT onset_NN and_CC the_DT severity_NN of_IN inflammation_NN ._.
        
      
      
        Discussion_NNP
        Because_IN PG-induced_NNP arthritis_NN is_VBZ dominated_VBN by_IN IFN-γ_NNP ,_, it_PRP
        is_VBZ considered_VBN to_TO be_VB a_DT Th_NNP 1_CD -_: type_NN disease_NN [_NN 4_CD ,_, 18_CD ]_NN ._.
        Paradoxically_NNP ,_, we_PRP observed_VBD higher_JJR concentrations_NNS of_IN the_DT
        IgG_NNP 1_CD isotype_NN than_IN of_IN the_DT IgG_NNP 2_CD a_DT isotype_NN ._. To_TO resolve_VB this_DT
        apparent_JJ paradox_NN ,_, we_PRP examined_VBD the_DT anti-_NN PG_NNP responses_NNS in_IN
        cytokine-deficient_JJ animals_NNS ._. We_PRP found_VBD that_IN in_IN the_DT absence_NN of_IN
        IL-_NNP 4_CD ,_, the_DT PG-specific_NNP IgG_NNP 1_CD isotype_NN was_VBD only_RB minimally_RB
        affected_VBN ._. These_DT 
        in_IN vivo_NN experiments_NNS are_VBP very_RB
        different_JJ from_IN those_DT describing_VBG a_DT dramatic_JJ 
        in_IN vitro_NN effect_NN of_IN IL-_NNP 4_CD on_IN IgG_NNP 1_CD
        induction_NN [_NN 9_CD ,_, 10_CD ]_NN ,_, but_CC are_VBP similar_JJ to_TO other_JJ studies_NNS that_WDT
        showed_VBD partial_JJ elimination_NN of_IN IgG_NNP 1_CD 
        in_IN vivo_NN ,_, either_CC using_VBG neutralizing_VBG
        antibodies_NNS to_TO IL-_NNP 4_CD or_CC blocking_VBG the_DT IL-_NNP 4_CD receptor_NN with_IN
        antibodies_NNS [_NN 11_CD ,_, 12_CD ,_, 13_CD ,_, 19_CD ]_NN ._. One_CD possibility_NN was_VBD that_IN the_DT
        large_JJ carbohydrate_NN content_NN of_IN PG_NNP might_MD have_VB a_DT promoting_VBG
        interaction_NN with_IN B_NNP cells_NNS in_IN a_DT mitogen-like_JJ manner_NN ,_, thus_RB
        permitting_VBG production_NN of_IN IgG_NNP 1_CD ._. However_RB ,_, nude_JJ mice_NNS and_CC
        CD_NNP 40_CD -_: deficient_NN mice_NNS did_VBD not_RB generate_VB a_DT PG-specific_NNP IgG_NNP 1_CD
        response_NN and_CC such_JJ a_DT response_NN was_VBD also_RB independent_JJ of_IN IFN-γ_NNP ._.
        Taken_VBN together_RB ,_, these_DT results_NNS are_VBP in_IN contrast_NN to_TO the_DT
        IL-_NNP 4_CD -_: dictated_VBN IgG_NNP 1_CD switch_VB response_NN ._. Rather_RB ,_, they_PRP suggest_VBP
        that_IN the_DT PG-specific_NNP IgG_NNP 1_CD response_NN ,_, at_IN least_JJS in_IN BALB_NNP /_NN c_SYM
        mice_NNS ,_, may_MD be_VB regulated_VBN 
        in_IN vivo_NN by_IN other_JJ ,_,
        as-yet-unidentified_JJ ,_, cytokine_NN (_( s_VBZ )_) [_NN 8_CD ,_, 20_CD ,_, 21_CD ,_, 22_CD ]_NN ._.
        In_IN contrast_NN to_TO IgG_NNP 1_CD ,_, the_DT expression_NN of_IN IgG_NNP 2_CD a_DT isotype_NN
        showed_VBD a_DT strong_JJ inverse_NN correlation_NN with_IN the_DT concentration_NN
        of_IN endogenous_JJ IL-_NNP 4_CD ._. In_IN the_DT absence_NN of_IN IL-_NNP 4_CD ,_, the_DT IgG_NNP 2_CD a_DT
        response_NN was_VBD six_CD times_NNS greater_JJR than_IN in_IN wild-type_JJ mice_NNS ._. This_DT
        finding_VBG demonstrates_VBZ that_IN IL-_NNP 4_CD plays_VBZ a_DT critical_JJ role_NN in_IN
        regulating_VBG the_DT PG-specific_NNP IgG_NNP 2_CD a_DT response_NN ._. The_DT role_NN of_IN this_DT
        cytokine_NN in_IN the_DT suppression_NN of_IN IgG_NNP 2_CD a_DT 
        in_IN vivo_NN has_VBZ not_RB been_VBN well_RB studied_VBN ._.
        The_DT IgG_NNP 2_CD a_DT response_NN was_VBD only_RB minimally_RB enhanced_VBN after_IN 
        in_IN vivo_NN treatment_NN with_IN anti-_NN IL-_NNP 4_CD
        antibody_NN [_NN 8_CD ]_NN ,_, but_CC it_PRP was_VBD increased_VBN in_IN immunized_JJ
        IL-_NNP 4_CD -_: deficient_NN mice_NNS [_NN 23_CD ]_NN ._. Since_IN there_EX is_VBZ no_DT evidence_NN that_IN
        IL-_NNP 4_CD directly_RB inhibits_NNS IgG_NNP 2_CD a_DT transcription_NN in_IN B_NNP cells_NNS ,_, this_DT
        cytokine_NN very_RB likely_JJ suppresses_NNS the_DT IFN-γ_NNP response_NN ,_, either_CC
        directly_RB or_CC indirectly_RB ._. Indeed_RB ,_, the_DT significant_JJ reduction_NN
        of_IN the_DT PG-specific_NNP IgG_NNP 2_CD a_DT response_NN in_IN the_DT absence_NN of_IN IFN-γ_NNP
        suggests_VBZ that_IN the_DT response_NN is_VBZ controlled_VBN by_IN this_DT
        interferon_NN ._.
        We_PRP have_VBP found_VBN that_IN the_DT development_NN of_IN PG-specific_NNP
        antibodies_NNS correlates_NNS with_IN the_DT development_NN of_IN arthritis_NN ,_,
        and_CC that_IN PG-specific_NNP autoantibodies_NNS increase_VBP the_DT severity_NN
        of_IN disease_NN ._. We_PRP show_VBP here_RB that_IN mice_NNS deficient_NN in_IN IL-_NNP 4_CD
        develop_VB arthritis_NN that_WDT is_VBZ significantly_RB more_RBR severe_JJ than_IN in_IN
        wild-type_JJ animals_NNS ._. The_DT pathogenic_JJ role_NN of_IN IgG_NNP 2_CD a_DT antibody_NN
        was_VBD also_RB described_VBN in_IN a_DT model_NN of_IN autoimmune_JJ hemolytic_JJ
        anemia_NN [_NN 24_CD ]_NN ;_: however_RB ,_, these_DT IgG_NNP 2_CD a_DT autoantibodies_NNS were_VBD not_RB
        pathogenic_JJ in_IN mice_NNS that_WDT are_VBP deficient_NN in_IN Fcγ_NNP receptor_NN III_NNP [_NN
        24_CD ]_NN ._. These_DT two_CD observations_NNS taken_VBN together_RB suggest_VBP the_DT
        possibility_NN that_IN the_DT IgG_NNP 2_CD a_DT PG-specific_NNP autoantibodies_NNS
        elicit_NN a_DT pathogenic_JJ effect_NN through_IN an_DT Fc-receptor-mediated_NNP
        mechanism_NN ._.
        PG-induced_NNP arthritis_NN is_VBZ considered_VBN a_DT Th_NNP 1_CD -_: type_NN disease_NN ,_,
        characterized_VBN by_IN a_DT higher_JJR ratio_NN of_IN IFN-γ_NNP to_TO IL-_NNP 4_CD [_NN 4_CD ]_NN ._. Our_PRP$
        finding_VBG that_DT treatment_NN with_IN IL-_NNP 4_CD inhibits_NNS IFN-γ_NNP suggests_VBZ
        that_IN IL-_NNP 4_CD could_MD mediate_VB a_DT shift_NN from_IN a_DT Th_NNP 1_CD to_TO a_DT Th_NNP 2_CD
        response_NN 
        in_IN vivo_NN [_NN 4_CD ]_NN ._. In_IN addition_NN to_TO the_DT
        effects_NNS of_IN IL-_NNP 4_CD on_IN antibody_NN production_NN ,_, this_DT cytokine_NN
        inhibits_NNS Th_NNP 1_CD responses_NNS ,_, including_VBG IFN-γ_NNP and_CC macrophage_NN
        production_NN of_IN proinflammatory_NN cytokines_NNS [_NN 25_CD ,_, 26_CD ]_NN ._. An_DT
        increase_NN in_IN inflammatory_JJ cytokine_NN production_NN in_IN
        IL-_NNP 4_CD -_: deficient_NN mice_NNS may_MD also_RB contribute_VB to_TO exacerbation_NN of_IN
        PG-induced_NNP arthritis_NN ._. In_IN adjuvant_NN arthritis_NN ,_, which_WDT may_MD not_RB
        be_VB dependent_JJ on_IN antibodies_NNS ,_, disease_NN is_VBZ increased_VBN in_IN the_DT
        absence_NN of_IN IL-_NNP 4_CD [_NN 27_CD ]_NN ._. This_DT finding_VBG suggests_VBZ that_IN IL-_NNP 4_CD
        inhibits_NNS adjuvant_NN arthritis_NN by_IN its_PRP$ anti-inflammatory_JJ
        properties_NNS and_CC not_RB by_IN an_DT alteration_NN in_IN isotype_NN expression_NN ._.
        Paradoxically_NNP ,_, in_IN collagen-induced_JJ arthritis_NN (_( CIA_NNP )_) ,_, disease_NN
        is_VBZ suppressed_VBN in_IN IL-_NNP 4_CD -_: deficient_NN mice_NNS [_NN 28_CD ]_NN ._. CIA_NNP is_VBZ also_RB
        different_JJ from_IN PG-induced_NNP arthritis_NN in_IN regard_NN to_TO IFN-γ_NNP ._. In_IN
        CIA_NNP and_CC some_DT other_JJ organ-specific_JJ autoimmune_JJ diseases_NNS ,_,
        IFN-γ_NNP functions_NNS in_IN a_DT protective_JJ role_NN ,_, so_IN that_IN in_IN
        IFN-γ-deficient_NNP mice_NNS disease_NN is_VBZ exacerbated_VBN [_NN 29_CD ,_, 30_CD ]_NN ._.
        Whether_IN the_DT difference_NN between_IN PG-induced_NNP arthritis_NN and_CC CIA_NNP
        is_VBZ due_JJ to_TO the_DT autoantigen_NN or_CC to_TO genetic_JJ differences_NNS in_IN
        mouse_NN strains_NNS is_VBZ not_RB clear_JJ at_IN present_NN ._.
      
      
        Conclusion_NNP
        Th_NNP 1_CD and_CC Th_NNP 2_CD cytokines_NNS regulate_VB PG-specific_NNP autoantibody_NN
        IgG_NNP isotypes_NNS and_CC susceptibility_NN to_TO arthritis_NN ._. In_IN the_DT
        absence_NN of_IN IL-_NNP 4_CD ,_, the_DT production_NN of_IN PG-specific_NNP IgG_NNP 2_CD a_DT
        isotype_NN was_VBD dramatically_RB enhanced_VBN and_CC disease_NN was_VBD
        significantly_RB more_RBR severe_JJ ._. IL-_NNP 4_CD may_MD exert_VB its_PRP$ effect_NN
        through_IN IFN-γ_NNP ,_, since_IN in_IN IFN-γ-deficient_NNP mice_NNS ,_, both_DT the_DT
        PG-specific_NNP IgG_NNP 2_CD a_DT response_NN and_CC arthritis_NN were_VBD suppressed_VBN ._.
        The_DT correlation_NN between_IN PG-specific_NNP autoantibody_NN isotype_NN
        and_CC development_NN of_IN arthritis_NN suggests_VBZ a_DT pathological_JJ role_NN
        for_IN IgG_NNP 2_CD a_DT isotype_NN in_IN disease_NN ._.
      
      
        Abbreviations_NNP
        CIA_NNP =_SYM collagen-induced_JJ arthritis_NN ;_: ELISA_NNP =_SYM enzyme-linked_JJ
        immunosorbent_NN assay_NN ;_: Th_NNP =_SYM T_NN helper_NN ;_: PG_NNP =_SYM proteoglycan_NN ;_: IFN_NNP
        =_SYM interferon_NN ;_: IL_NNP =_SYM interleukin_NN ;_: SEM_NNP =_SYM standard_JJ error_NN of_IN the_DT
        mean_NN ._.
      
    
  
